Home
>
National Drug Code (NDC)
>
ZYPREXA
ZYPREXA - 0002-7597-01 - (Olanzapine)
Drug Information of ZYPREXA
| Product NDC: | 0002-7597 |
| Proprietary Name: | ZYPREXA |
| Non Proprietary Name: | Olanzapine |
| Active Ingredient(s): | 10 mg/2mL & nbsp; Olanzapine |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZYPREXA
| Product NDC: | 0002-7597 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021253 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040401 |
Package Information of ZYPREXA
| Package NDC: | 0002-7597-01 |
| Package Description: | 1 VIAL in 1 CARTON (0002-7597-01) > 2 mL in 1 VIAL |
NDC Information of ZYPREXA
| NDC Code | 0002-7597-01 |
| Proprietary Name | ZYPREXA |
| Package Description | 1 VIAL in 1 CARTON (0002-7597-01) > 2 mL in 1 VIAL |
| Product NDC | 0002-7597 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Olanzapine |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20040401 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | OLANZAPINE |
| Strength Number | 10 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
